JAM-A/CD321

JAM-A (CD321), encoded by F11R, is a member of the junctional adhesion molecule family that localizes to tight junctions of endothelial and epithelial cells through its PDZ-binding cytoplasmic motif. On the luminal surface it serves as a counter-receptor for the leukocyte integrin LFA-1, guiding neutrophils and monocytes across the endothelial barrier during inflammation, and it also supports platelet interactions via self-association on platelet surfaces. JAM-A doubles as a virus receptor, since reovirus type 1 uses it for entry, and it participates in tight junction assembly and barrier permeability regulation. Epithelial overexpression of JAM-A has been linked to breast cancer progression, extending its relevance beyond leukocyte trafficking.